INVESTIGADORES
RAMIREZ Dario
congresos y reuniones científicas
Título:
MUTAGENESIS INDUCED BY INTRACELLULAR PRODUCED HOCL IN AIRWAY EPITHELIAL CELLS
Autor/es:
SANDRA E. GOMEZ-MEJIBA; MARIA S. GIMENEZ; DARIO C. RAMIREZ
Lugar:
ORLANDO, FL
Reunión:
Congreso; 17TH ANNUAL MEETING OF THE SFRBM; 2010
Resumen:
MUTAGENESIS INDUCED BY
INTRACELLULARLY PRODUCED HOCL IN
AIRWAY EPITHELIAL CELLS
SANDRA E GOMEZ-MEJIBA1,2, MARIA S GIMENEZ2, ZILI ZHAI1,
and DARIO C RAMIREZ11,2, MARIA S GIMENEZ2, ZILI ZHAI1,
and DARIO C RAMIREZ11
1OMRF, Oklahoma City, OK, USA, 2IMIBIO-SL, UNSL, SAN
LUIS, ARGENTINAOMRF, Oklahoma City, OK, USA, 2IMIBIO-SL, UNSL, SAN
LUIS, ARGENTINA, MARIA S GIMENEZ2, ZILI ZHAI1,
and DARIO C RAMIREZ11
1OMRF, Oklahoma City, OK, USA, 2IMIBIO-SL, UNSL, SAN
LUIS, ARGENTINAOMRF, Oklahoma City, OK, USA, 2IMIBIO-SL, UNSL, SAN
LUIS, ARGENTINA
Neutrophil infiltration is thought to be a key event in lung
carcinogenesis induced by acute irritation of the airways.
Myeloperoxidase (MPO) is present in the azurolphils granules of
neutrophils and released upon activation. During acute injury of
the lung by endotoxin, infiltrating and activated neutrophils
release a large amount of MPO in the airways. Myeloperoxidase
is the only mammalian enzyme that produces HOCl at
physiological pH. Herein we sought to tests whether
intracellularly produced HOCl causes genotoxicity and affect the
repair mechanisms in airway epithelial cells that lead to
mutations. Upon co-incubation with activated human neutrophils
released MPO is accumulated inside A549 airway epithelial
cells. Exposure of these cells to a flow of H2O2, MPO produced
HOCl inside the cell that causes DNA-centered radicals, 8-oxodG,
and mutations in the hypoxanthine-guanine
phosporibosyltransferase (HPRT) gene. We determined DNAcentered
radicals by trapping them in situ and in real time with
DMPO to form DNA-DMPO nitrone adducts and thus further
oxidation and mutagenicity is prevented. We determined the
frequency of mutation of the HPRT gene by selecting cells
resistant to 6-thioguanine. Cells with a mutation in this gene
survive in medium containing 6-TG, whereas non-mutated cells
die. We determined uptake of MPO released form neutrophils
and intracellularly produced HOCl using immunochemistry and
aminophenyl fluorescein (APF), respectively. Inactivated MPO
did not produce APF fluorescence, DNA-centered radicals, 8-
oxo-dG or mutations in A549 cells. APF fluorescence was
prevented with cell permeable inhibitors of MPO activity and
resveratrola cell permeable scavenger of HOCl, but not
affected by DMPO. DMPO treatment resulted in reduced 8-oxodG,
increased nitrone adducts and blocked HPRT gene
mutation. HPRT gene mutation was due to intracellularly
produced HOCl but not HOCl produced by extracellular MPO.
Our findings establish the critical role of the transient formation
of DNA-centered radical during mutagenesis produced by HOCl
generated inside epithelial cells that might explain neutrophilic
inflammation-induced lung carcinogenesis. Inhibitors of MPO,
cell permeable scavengers of HOCl or spin traps may help
prevent this process. Supported by NIEHS 5R00ES015415-04.(HPRT) gene. We determined DNAcentered
radicals by trapping them in situ and in real time with
DMPO to form DNA-DMPO nitrone adducts and thus further
oxidation and mutagenicity is prevented. We determined the
frequency of mutation of the HPRT gene by selecting cells
resistant to 6-thioguanine. Cells with a mutation in this gene
survive in medium containing 6-TG, whereas non-mutated cells
die. We determined uptake of MPO released form neutrophils
and intracellularly produced HOCl using immunochemistry and
aminophenyl fluorescein (APF), respectively. Inactivated MPO
did not produce APF fluorescence, DNA-centered radicals, 8-
oxo-dG or mutations in A549 cells. APF fluorescence was
prevented with cell permeable inhibitors of MPO activity and
resveratrola cell permeable scavenger of HOCl, but not
affected by DMPO. DMPO treatment resulted in reduced 8-oxodG,
increased nitrone adducts and blocked HPRT gene
mutation. HPRT gene mutation was due to intracellularly
produced HOCl but not HOCl produced by extracellular MPO.
Our findings establish the critical role of the transient formation
of DNA-centered radical during mutagenesis produced by HOCl
generated inside epithelial cells that might explain neutrophilic
inflammation-induced lung carcinogenesis. Inhibitors of MPO,
cell permeable scavengers of HOCl or spin traps may help
prevent this process. Supported by NIEHS 5R00ES015415-04.HPRT gene by selecting cells
resistant to 6-thioguanine. Cells with a mutation in this gene
survive in medium containing 6-TG, whereas non-mutated cells
die. We determined uptake of MPO released form neutrophils
and intracellularly produced HOCl using immunochemistry and
aminophenyl fluorescein (APF), respectively. Inactivated MPO
did not produce APF fluorescence, DNA-centered radicals, 8-
oxo-dG or mutations in A549 cells. APF fluorescence was
prevented with cell permeable inhibitors of MPO activity and
resveratrola cell permeable scavenger of HOCl, but not
affected by DMPO. DMPO treatment resulted in reduced 8-oxodG,
increased nitrone adducts and blocked HPRT gene
mutation. HPRT gene mutation was due to intracellularly
produced HOCl but not HOCl produced by extracellular MPO.
Our findings establish the critical role of the transient formation
of DNA-centered radical during mutagenesis produced by HOCl
generated inside epithelial cells that might explain neutrophilic
inflammation-induced lung carcinogenesis. Inhibitors of MPO,
cell permeable scavengers of HOCl or spin traps may help
prevent this process. Supported by NIEHS 5R00ES015415-04.HPRT gene
mutation. HPRT gene mutation was due to intracellularly
produced HOCl but not HOCl produced by extracellular MPO.
Our findings establish the critical role of the transient formation
of DNA-centered radical during mutagenesis produced by HOCl
generated inside epithelial cells that might explain neutrophilic
inflammation-induced lung carcinogenesis. Inhibitors of MPO,
cell permeable scavengers of HOCl or spin traps may help
prevent this process. Supported by NIEHS 5R00ES015415-04.